Biogen, Inc. (BIIB)
219.88
-2.94
(-1.32%)
USD |
NASDAQ |
Oct 02, 16:00
219.10
-0.78
(-0.35%)
After-Hours: 20:00
Biogen Price : 219.88 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 222.98 | 224.08 | 219.81 | 219.88 | 780428.0 |
| Oct 01, 2026 | 225.50 | 228.31 | 222.50 | 222.82 | 1.755M |
| Sep 30, 2026 | 227.23 | 229.36 | 225.50 | 225.88 | 1.553M |
| Sep 29, 2026 | 227.02 | 229.41 | 224.45 | 227.07 | 1.161M |
| Sep 28, 2026 | 225.87 | 230.49 | 225.51 | 228.69 | 1.332M |
| Sep 25, 2026 | 228.27 | 228.92 | 223.76 | 227.60 | 958031.0 |
| Sep 24, 2026 | 226.80 | 228.72 | 224.30 | 226.36 | 1.035M |
| Sep 23, 2026 | 226.94 | 229.19 | 222.36 | 227.53 | 1.494M |
| Sep 22, 2026 | 219.22 | 226.43 | 219.00 | 225.36 | 1.112M |
| Sep 21, 2026 | 216.14 | 221.92 | 214.59 | 219.07 | 928562.0 |
| Sep 18, 2026 | 219.05 | 220.17 | 215.26 | 215.50 | 2.636M |
| Sep 17, 2026 | 217.68 | 219.41 | 215.33 | 219.05 | 836707.0 |
| Sep 16, 2026 | 216.41 | 218.29 | 214.81 | 216.01 | 606493.0 |
| Sep 15, 2026 | 216.71 | 216.71 | 213.54 | 216.17 | 756047.0 |
| Sep 14, 2026 | 221.00 | 222.24 | 215.56 | 217.36 | 629931.0 |
| Sep 11, 2026 | 216.75 | 219.76 | 214.71 | 217.15 | 1.076M |
| Sep 10, 2026 | 209.92 | 216.70 | 208.93 | 215.43 | 936643.0 |
| Sep 09, 2026 | 210.50 | 213.48 | 209.00 | 210.73 | 694669.0 |
| Sep 08, 2026 | 215.45 | 217.28 | 210.54 | 212.50 | 617829.0 |
| Sep 04, 2026 | 221.15 | 223.82 | 219.82 | 220.83 | 465108.0 |
| Sep 03, 2026 | 225.44 | 225.80 | 221.23 | 224.51 | 550745.0 |
| Sep 02, 2026 | 218.20 | 225.59 | 216.97 | 222.67 | 1.268M |
| Sep 01, 2026 | 218.11 | 219.30 | 213.60 | 216.04 | 785497.0 |
| Aug 31, 2026 | 216.47 | 218.89 | 213.58 | 216.65 | 831004.0 |
| Aug 28, 2026 | 221.17 | 222.00 | 216.78 | 218.50 | 517485.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ionis Pharmaceuticals, Inc. | 43.54 |
| AbbVie, Inc. | 262.82 |
| Gilead Sciences, Inc. | 144.74 |
| Regeneron Pharmaceuticals, Inc. | 735.20 |
| Amgen, Inc. | 403.04 |
Price Related Metrics
| PE Ratio | 38.94 |
| PS Ratio | 3.362 |
| Price to Book Value | 1.723 |
| Price to Free Cash Flow | 13.04 |
| Earnings Yield | 2.57% |
| Market Cap | 32.48B |
| Operating PE Ratio | 17.25 |
| Normalized PE Ratio | 24.07 |